World Health Organisation (WHO) on Wednesday granted approval to India’s indigenous Covid vaccine Covaxin– for emergency use on age groups 18 and above all. Continue reading Bharat Biotech’s Covaxin approved by WHO for emergency use
The announcement came after, PM Modi’s speech at the G20 Summit regarding the delay in recognition of Covaxin by the WHO.
The agency said that when the information provided addresses all questions raised, the WHO and the technical advisory group will complete the assessment and come to a final recommendation on whether to grant EUL to the vaccine. Continue reading ‘Cannot cut corners’: WHO says awaiting additional information on Covaxin
WHO is supporting the special day by boosting awareness of mental health issues as well as creating technical and interpersonal materials.
The widely used Sputnik V shot in Russia approved for use in over 70 countries is undergoing a review by the WHO and the European Medicines Agency (EMA). Continue reading WHO says ‘near’ to solving issues on Russia’s Sputnik V vaccine
October 6th marked a new day in medical history as World Health Organisation recommended the broad use of the world’s first malaria vaccine.
Dr. VK Paul, National Expert Committee chairman for Vaccine Administration told reporters that the WHO’s acceptance for emergency utilization of Covaxin, which will announce it secure for the use in other countries and ultimately allow people who receive the vaccine to travel overseas without prescribed quarantine, could come before the end of September. Continue reading Covaxin approval from WHO by the end of September 2021 says Niti Aayog